Advertisement

Investigating increasingly complex resistance in Enterobacteriaceae & Pseudomonas aeruginosa in critical care

      Background: Time to appropriate antimicrobial therapy in critical care sepsis directly impacts outcome, with knowledge of resistance patterns being key. We investigate resistance trends in Enterobacteriaceae and Pseudomonas aeruginosa from critical care units in two UK tertiary referral hospitals to explore the utility of continued reliance on piperacillin-tazobactam and carbapenems in the empiric management of sepsis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect